Skip to main content
Equibles

Man Group plc

Position in RARE — Ultragenyx Pharmaceutical Inc.

CIK 1637460 LONDON, X0
Back to RARE Full portfolio

Position in RARE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$6,514,722
+$2,044,999 QoQ
Shares Held
195,110
-8.6% QoQ
Ownership
0.198%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#71
of 311 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 76% Shared 0% None 24%

Common Shares in RARE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Man Group plc holds $1,100,351,284 across 114 Biotechnology names. RARE ranks #23 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 436,956 $272,459,544
2 INCY
Incyte Corp
 952,941 $108,025,391
3 ONC
BeOne Medicines Ltd.
 307,463 $87,617,731
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 139,233 $69,161,207
5
397,000 $52,693,809
6 ALNY
Alnylam Pharmaceuticals, Inc.
 170,907 $51,448,133
7 JAZZ
Jazz Pharmaceuticals plc
 152,877 $36,838,770
8 RVMD
Revolution Medicines, Inc.
 173,439 $32,481,655

All Filings in RARE

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,514,722 195,110
2026-03-31 $4,469,723 213,352
2025-12-31 $1,802,533 78,371
2025-09-30 $215,132 7,152
2025-06-30 $6,696,675 184,177
2025-03-31 $16,480,909 455,148
2024-12-31 $12,511,364 297,394
2024-09-30 $18,176,125 327,203
2024-06-30 $25,840,638 628,726
2024-03-31 $7,173,497 153,641
2023-12-31 $4,199,121 87,811
2023-09-30 $831,999 23,338
2023-06-30 $1,950,238 42,277
2023-03-31 $806,851 20,121
2022-12-31 $1,770,314 38,211
2022-09-30 $1,426,077 34,438
2022-06-30 $1,561,660 26,176
2022-03-31 $488,296 6,724
2021-03-31 $1,895,199 16,645
2020-12-31 $6,249,837 45,148
2020-09-30 $2,678,818 32,593
2020-06-30 $2,235,292 28,577
2020-03-31 $1,659,371 37,348